Deciphera Pharmaceuticals, Inc. D05.F Stock
Deciphera Pharmaceuticals, Inc. Price Chart
Deciphera Pharmaceuticals, Inc. D05.F Financial and Trading Overview
| Deciphera Pharmaceuticals, Inc. stock price | 14.5 EUR |
| Previous Close | 12.83 EUR |
| Open | 13.05 EUR |
| Bid | 13.05 EUR x 0 |
| Ask | 13.51 EUR x 0 |
| Day's Range | 13.05 - 13.05 EUR |
| 52 Week Range | 10.23 - 21.14 EUR |
| Volume | 30 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 1.02B EUR |
| Beta (5Y Monthly) | 0.668309 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.13 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 66.9 EUR |
D05.F Valuation Measures
| Enterprise Value | 680.35M EUR |
| Trailing P/E | N/A |
| Forward P/E | -3.4523811 |
| PEG Ratio (5 yr expected) | -0.32 |
| Price/Sales (ttm) | 7.411839 |
| Price/Book (mrq) | 2.327863 |
| Enterprise Value/Revenue | 4.921 |
| Enterprise Value/EBITDA | -3.652 |
Trading Information
Deciphera Pharmaceuticals, Inc. Stock Price History
| Beta (5Y Monthly) | 0.668309 |
| 52-Week Change | 30.79% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 21.14 EUR |
| 52 Week Low | 10.23 EUR |
| 50-Day Moving Average | 13.01 EUR |
| 200-Day Moving Average | 15.2 EUR |
D05.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 78.52M |
| Float | 41.02M |
| Short Ratio | N/A |
| % Held by Insiders | 29.98% |
| % Held by Institutions | 73.08% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -131.38% |
| Operating Margin (ttm) | -136.76% |
| Gross Margin | -47.58% |
| EBITDA Margin | -134.75% |
Management Effectiveness
| Return on Assets (ttm) | -25.29% |
| Return on Equity (ttm) | -51.049% |
Income Statement
| Revenue (ttm) | 138.26M EUR |
| Revenue Per Share (ttm) | 1.7 EUR |
| Quarterly Revenue Growth (yoy) | 14.39% |
| Gross Profit (ttm) | -62555000 EUR |
| EBITDA | -186316000 EUR |
| Net Income Avi to Common (ttm) | -181648000 EUR |
| Diluted EPS (ttm) | -2.11 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 398.63M EUR |
| Total Cash Per Share (mrq) | 5.08 EUR |
| Total Debt (mrq) | 28.32M EUR |
| Total Debt/Equity (mrq) | 6.44 EUR |
| Current Ratio (mrq) | 5.674 |
| Book Value Per Share (mrq) | 5.606 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -150964992 EUR |
| Levered Free Cash Flow (ttm) | -83792376 EUR |
Profile of Deciphera Pharmaceuticals, Inc.
| Country | Germany |
| State | MA |
| City | Waltham |
| Address | 200 Smith Street |
| ZIP | 02451 |
| Phone | 781 209 6400 |
| Website | https://www.deciphera.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 300 |
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing medicines to improve the lives of cancer patients in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 in combination with RTK/RAS/MAP kinase signaling pathway inhibition to treat RAS/RAF mutant cancers. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.
Q&A For Deciphera Pharmaceuticals, Inc. Stock
What is a current D05.F stock price?
Deciphera Pharmaceuticals, Inc. D05.F stock price today per share is 14.5 EUR.
How to purchase Deciphera Pharmaceuticals, Inc. stock?
You can buy D05.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Deciphera Pharmaceuticals, Inc.?
The stock symbol or ticker of Deciphera Pharmaceuticals, Inc. is D05.F.
Which industry does the Deciphera Pharmaceuticals, Inc. company belong to?
The Deciphera Pharmaceuticals, Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Deciphera Pharmaceuticals, Inc. have in circulation?
The max supply of Deciphera Pharmaceuticals, Inc. shares is 80.8M.
What is Deciphera Pharmaceuticals, Inc. Price to Earnings Ratio (PE Ratio)?
Deciphera Pharmaceuticals, Inc. PE Ratio is now.
What was Deciphera Pharmaceuticals, Inc. earnings per share over the trailing 12 months (TTM)?
Deciphera Pharmaceuticals, Inc. EPS is -2.13 EUR over the trailing 12 months.
Which sector does the Deciphera Pharmaceuticals, Inc. company belong to?
The Deciphera Pharmaceuticals, Inc. sector is Healthcare.